Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in Paraffin sections

Modern Pathology

Volumn 10, Issue 9, 1997, Pages 859-863

  Dorfman, David M ^a   Shahsafaei, Aliakbar ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chronic lymphocytic leukemia; Immunohistochemistry; Mantle cell lymphoma; Non Hodgkin's lymphoma; Small lymphocytic lymphoma

Indexed keywords

ANTIBODY; CD5 ANTIGEN; PARAFFIN;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD5; HISTOLOGICAL TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; LYMPHOMA, LYMPHOBLASTIC; LYMPHOMA, SMALL LYMPHOCYTIC; LYMPHOMA, T-CELL; PARAFFIN EMBEDDING;

EID: 0030844807     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Arber DA, Weiss LM. CD5: a review. Appl Immunohistochem 1995;3:1-22.
2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994;84:1361-92.
3. Dorfman DM, Pinkus GS. Utility of immunophenotypic studies in the diagnosis of low-grade lymphoma of mucosa-associated lymphoid tissue (MALT) and other low-grade non-Hodgkin's lymphomas of extranodal sites. Appl Immunohistochem 1995;3:160-7.
4. Dorfman DM, Pinkus GS. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol 1994;7:326-31.
5. Ben-Ezra JM, Kornstein MJ. Antibody NCL-CD5 fails to detect neoplastic CD5+ cells in paraffin sections. Am J Clin Pathol 1996;106:370-3.
6. Kilo MN, Dorfman DM. The utility of flow cytometric analysis in the distinction of small lymphocytic lymphoma from mantle cell lymphoma. Am J Clin Pathol 1996;105:451-7.
7. Kumar S, Green GA, Teruya-Feldstein J, Raffield M, Jaffe ES. Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma. Mod Pathol 1996;9:925-9.
8. Weisenberger DD, Armitage JO. Mantle cell lymphoma: an entity comes of age. Blood 1996;87:4483-94.
9. Gogolin-Ewens K, Meeusen E, Lee CS, Brandon M. Expression of CD5, a lymphocyte surface antigen on the endothelium of blood vessels. Eur J Immunol 1989;19:935-8.
10. Hishima T, Fukayama M, Fujisawa M, Hayashi Y, Arai K, Funata N, et al. CD5 expression in thymic carcinoma. Am J Pathol 1994;145:268-75.
11. Dorfman DM, Shahsafaei A, Chan JKC. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Am J Surg Pathol 1997;21:936-40.